CN117618285A - Skin cosmetic and emulsified cosmetic - Google Patents
Skin cosmetic and emulsified cosmetic Download PDFInfo
- Publication number
- CN117618285A CN117618285A CN202311057622.3A CN202311057622A CN117618285A CN 117618285 A CN117618285 A CN 117618285A CN 202311057622 A CN202311057622 A CN 202311057622A CN 117618285 A CN117618285 A CN 117618285A
- Authority
- CN
- China
- Prior art keywords
- group
- component
- mass
- oxyethylene
- ltoreq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 85
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 36
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims abstract description 5
- -1 oxybutylene group Chemical group 0.000 claims description 56
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 40
- 125000006353 oxyethylene group Chemical group 0.000 claims description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 150000001875 compounds Chemical class 0.000 claims description 22
- 125000005702 oxyalkylene group Chemical group 0.000 claims description 22
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 15
- 239000002736 nonionic surfactant Substances 0.000 claims description 15
- 150000005846 sugar alcohols Polymers 0.000 claims description 4
- 239000008041 oiling agent Substances 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000003020 moisturizing effect Effects 0.000 abstract description 16
- 206010039792 Seborrhoea Diseases 0.000 abstract description 9
- 230000037312 oily skin Effects 0.000 abstract description 9
- 229920005862 polyol Polymers 0.000 abstract description 3
- 150000003077 polyols Chemical class 0.000 abstract description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 53
- 230000000475 sunscreen effect Effects 0.000 description 39
- 239000000516 sunscreening agent Substances 0.000 description 39
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 36
- 210000003491 skin Anatomy 0.000 description 32
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 31
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 26
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- 230000015572 biosynthetic process Effects 0.000 description 24
- 239000003054 catalyst Substances 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 24
- 238000003786 synthesis reaction Methods 0.000 description 24
- 238000011156 evaluation Methods 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 20
- 235000014113 dietary fatty acids Nutrition 0.000 description 20
- 239000000194 fatty acid Substances 0.000 description 20
- 229930195729 fatty acid Natural products 0.000 description 20
- 239000011248 coating agent Substances 0.000 description 18
- 238000000576 coating method Methods 0.000 description 18
- 150000003839 salts Chemical class 0.000 description 17
- 230000002087 whitening effect Effects 0.000 description 16
- 150000004665 fatty acids Chemical class 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 239000007795 chemical reaction product Substances 0.000 description 12
- 230000018044 dehydration Effects 0.000 description 12
- 238000006297 dehydration reaction Methods 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 230000001771 impaired effect Effects 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 8
- RBACIKXCRWGCBB-UHFFFAOYSA-N 1,2-Epoxybutane Chemical compound CCC1CO1 RBACIKXCRWGCBB-UHFFFAOYSA-N 0.000 description 8
- 229940071085 lauroyl glutamate Drugs 0.000 description 8
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 235000002378 plant sterols Nutrition 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000010696 ester oil Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 238000012644 addition polymerization Methods 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 229940093629 isopropyl isostearate Drugs 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 2
- PHTZMGCAFZLFOL-UHFFFAOYSA-N 14-methylpentadecyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCCCCCCCCCCCCCC(C)C PHTZMGCAFZLFOL-UHFFFAOYSA-N 0.000 description 2
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 2
- VRBHTEGUHVNKEA-UHFFFAOYSA-N 16-methylheptadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C VRBHTEGUHVNKEA-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 2
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 2
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 2
- NAGVKZOTMXGCCA-UHFFFAOYSA-N 2-ethylhexyl 7-methyloctanoate Chemical compound CCCCC(CC)COC(=O)CCCCCC(C)C NAGVKZOTMXGCCA-UHFFFAOYSA-N 0.000 description 2
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 2
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 2
- BRORPGSJXSLXKN-UHFFFAOYSA-N 6-methylheptyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCOC(=O)CC(C)CC(C)(C)C BRORPGSJXSLXKN-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 229940117933 isocetyl ethylhexanoate Drugs 0.000 description 2
- 229940078568 isocetyl myristate Drugs 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- SIOLDWZBFABPJU-UHFFFAOYSA-N isotridecanoic acid Chemical compound CC(C)CCCCCCCCCC(O)=O SIOLDWZBFABPJU-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZVCAOYTXHAHVFI-ZABJOTOOSA-N 1-O-(2-hexyldecyl) 5-O-(2-octyldodecyl) (2S)-2-(dodecanoylamino)pentanedioate Chemical compound CCCCCCCCCCCC(=O)N[C@@H](CCC(=O)OCC(CCCCCCCC)CCCCCCCCCC)C(=O)OCC(CCCCCC)CCCCCCCC ZVCAOYTXHAHVFI-ZABJOTOOSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 1
- WGKHLTQBAAWSSR-UHFFFAOYSA-N 16-methylheptadecyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCCCCCCCCCCCCCCCC(C)C WGKHLTQBAAWSSR-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- LBPNCQGSZHRGME-UHFFFAOYSA-N 2,2,3,3,4,4-hexahydroxyoctadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)(O)C(O)(O)C(O)(O)C(O)=O LBPNCQGSZHRGME-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- OATHWIHWTWDNLJ-UHFFFAOYSA-N 2-(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCCCCCCCC(C)C OATHWIHWTWDNLJ-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- UMHYVXGZRGOICM-AUYXYSRISA-N 2-[(z)-octadec-9-enoyl]oxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC\C=C/CCCCCCCC UMHYVXGZRGOICM-AUYXYSRISA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- JEMDXOYRWHZUCG-UHFFFAOYSA-N 2-octadecanoyloxypropyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCCCCCCCCCC JEMDXOYRWHZUCG-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- BIBSVSRJRVSBNF-MFERNQICSA-N 5-o-octadecanoyl 1-o-(9-octylicosan-9-yl) (2s)-2-aminopentanedioate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)CC[C@H](N)C(=O)OC(CCCCCCCC)(CCCCCCCC)CCCCCCCCCCC BIBSVSRJRVSBNF-MFERNQICSA-N 0.000 description 1
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 1
- PLLBRTOLHQQAQQ-UHFFFAOYSA-N 8-methylnonan-1-ol Chemical compound CC(C)CCCCCCCO PLLBRTOLHQQAQQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 108010035532 Collagen Chemical class 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- PSFABYLDRXJYID-VKHMYHEASA-N N-Methylserine Chemical compound CN[C@@H](CO)C(O)=O PSFABYLDRXJYID-VKHMYHEASA-N 0.000 description 1
- PSFABYLDRXJYID-UHFFFAOYSA-N N-methyl-DL-serine Natural products CNC(CO)C(O)=O PSFABYLDRXJYID-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- OBTJPZZDLMDTOI-DPDRHGIRSA-N bis(16-methylheptadecyl) (2S)-2-(dodecanoylamino)pentanedioate Chemical compound CCCCCCCCCCCC(=O)N[C@@H](CCC(=O)OCCCCCCCCCCCCCCCC(C)C)C(=O)OCCCCCCCCCCCCCCCC(C)C OBTJPZZDLMDTOI-DPDRHGIRSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WELLEIPLAKZPQH-DZJLPJKCSA-N bis(2-hexyldecyl) (2s)-2-(dodecanoylamino)pentanedioate Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(=O)OCC(CCCCCC)CCCCCCCC)CCC(=O)OCC(CCCCCC)CCCCCCCC WELLEIPLAKZPQH-DZJLPJKCSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940048851 cetyl ricinoleate Drugs 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 229920001436 collagen Chemical class 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- HCQHIEGYGGJLJU-UHFFFAOYSA-N didecyl hexanedioate Chemical compound CCCCCCCCCCOC(=O)CCCCC(=O)OCCCCCCCCCC HCQHIEGYGGJLJU-UHFFFAOYSA-N 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- KWABLUYIOFEZOY-UHFFFAOYSA-N dioctyl butanedioate Chemical compound CCCCCCCCOC(=O)CCC(=O)OCCCCCCCC KWABLUYIOFEZOY-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- 235000019866 hydrogenated palm kernel oil Nutrition 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- ASKIVFGGGGIGKH-UHFFFAOYSA-N isostearic acid monoglyceride Natural products CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- PIUVNPNBPWVVKZ-UHFFFAOYSA-N octadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC PIUVNPNBPWVVKZ-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- 229940010310 propylene glycol dioleate Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229940095068 tetradecene Drugs 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 229960004747 ubidecarenone Drugs 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Abstract
The invention provides a skin cosmetic which has fresh touch feeling when being coated, has excellent moisturizing feeling after a mask is worn for a long time and is taken off, and can inhibit oily and greasy feel of a person wearing oily skin after the mask is worn for a long time. The skin cosmetic contains 0.1-25% by mass ofComponent (a), component (b) in an amount of 0.01 to 3% by mass, component (c) in an amount of 0.1 to 25% by mass, and component (d), wherein the mass ratio ((b)/(a)) of component (b) to component (a) is 1/100 to 1/5: (a) Polyalkylene oxide derivatives represented by the formula (1), Z- [ O (AO) l (EO) m (BO) n ‑H] p … (1); (b) Alkylene oxide derivatives represented by formula (2), R- [ (PO) x (EO) y ] q -H … (2); (c) a polyol having 2 to 6 carbon atoms; (d) water.
Description
Technical Field
The present invention relates to a skin cosmetic which is fresh to the touch at the time of application, gives excellent moist feeling after wearing a mask for a long period of time and is removed, and suppresses oily and sticky feel of a person who has oily skin for a long period of time.
The present invention also relates to an emulsified cosmetic which is excellent in touch feeling at the time of application, improves adhesion of a sunscreen cosmetic to skin, and improves whitening of the sunscreen cosmetic.
Background
It is generally considered important to maintain the moisture balance (moistures balance) of the skin in order to maintain skin health. Moisturizing balance refers to the balance between moisture, sebum, natural Moisturizing Factor (NMF) of the stratum corneum of the skin. By applying cosmetics to the skin, replenishment of water-humectant-oil equivalent to these three components is important for maintaining moisture balance.
To prevent dryness of skin, cosmetics blended with various moisturizing components or a plurality of moisturizing components have been developed. Patent document 1 reports that a cosmetic containing a specific alkylene oxide derivative has excellent moisturizing effect and no sticky feeling.
Patent document 2 discloses that a cosmetic containing a specific compound such as ceramide and butanol or a specific alkylene oxide derivative can reduce the feel of a film on the skin, and is refreshing in use and excellent in the lasting feel of a moisturizing effect.
The sunscreen cosmetic has effect in protecting skin from ultraviolet injury. Ultraviolet-shielding components are broadly classified into ultraviolet absorbers and ultraviolet scattering agents, and particularly ultraviolet scattering agents are used in the fields of sensitive skin and infants because they are less irritating to the skin than ultraviolet absorbers. However, the sunscreen cosmetic has technical problems such as stickiness, easy caking and whitening, low affinity to skin, poor adhesion, and the like.
Patent document 3 provides a sunscreen cosmetic in which fine particles of zinc oxide surface-treated with an N-acyl amino acid or a salt thereof, volatile oil components, and trimethylsilyloxy silicate are combined to improve the astringent or dry feel of the skin after application.
Patent document 4 discloses an oil-in-water type sunscreen cosmetic which is free from a feeling of astringency at the time of application, has good extensibility on the skin, and does not turn white after application by combining titanium oxide particles subjected to surface treatment, a water-soluble polymer having a structural unit derived from acrylic acid or sulfonic acid, a nonionic surfactant having an HLB of 6 to 10, and an oil agent.
Prior art literature
Patent literature
Patent document 1: WO2006/038724A1
Patent document 2: japanese patent laid-open No. 2021-80234
Patent document 3: japanese patent application laid-open No. 2018-8910
Patent document 4: japanese patent laid-open publication No. 2017-197434
Disclosure of Invention
Technical problem to be solved by the invention
In order to maintain the moisture balance, it is necessary to select the most suitable cosmetic according to the external environment. In recent years, it has been necessary to wear a mask due to the spread of infectious diseases, so that the external environment of the skin may vary greatly in one day. In particular, when the mask is worn for a long period of time, although the humidity in the mask increases, if the moisture in the mask evaporates when the mask is removed, the moisture in the skin rapidly evaporates and gradually dries. In order to maintain the moisture balance even in such a situation where rapid evaporation of water occurs, it is necessary to blend a humectant or an oil at a high level. However, the following technical problems are thereby created: a sticky feeling is generated during application, a refreshing feeling during application is impaired, and oily skin is generated by people.
In contrast, the cosmetic described in patent document 1 cannot suppress the sticky feeling for a long period of time, and the moisturizing effect by rapid evaporation of moisture when the mask is removed is insufficient.
In addition, the cosmetic of patent document 2 has a technical problem that the moisturizing effect by rapid evaporation of moisture when the mask is removed is insufficient, and that oily skin is generated by a person.
The present invention aims to provide a skin cosmetic which is fresh and cool to the touch at the time of coating, has excellent moisturizing effect after a mask is worn for a long time and is taken off, and can suppress the oily and greasy feel of a person wearing oily skin after the mask for a long time.
The sunscreen cosmetic described in patent document 3 is not sufficient in terms of no whitening. The oil-in-water type sunscreen cosmetic described in patent document 4 is insufficient in adhesion to the skin.
The present invention aims to provide a cosmetic which is free from stickiness at the time of application, has excellent emulsion stability, improves adhesion of a sunscreen cosmetic to the skin, and improves whitening of the sunscreen cosmetic.
Technical means for solving the technical problems
In order to solve the above technical problems, the inventors of the present application have found that a skin cosmetic in which the specific two alkylene oxide derivatives and the polyhydric alcohol are combined in a specific ratio thoroughly solves the above technical problems.
Namely, the first invention is as follows.
A skin cosmetic comprising 0.1 to 25% by mass of the following component (a), 0.01 to 3% by mass of the following component (b), 0.1 to 25% by mass of the following component (c) and the following component (d), wherein the mass ratio ((b)/(a)) of the component (b) to the component (a) is 1/100 to 1/5:
(a) Polyalkylene oxide derivatives represented by the following formula (1),
Z-[O(AO) l (EO) m (BO) n -H] p …(1)
in the formula (1), the components are as follows,
z is a residue obtained by removing all hydroxyl groups from an alcohol having 3 to 9 carbon atoms,
p is the valence of the alcohol, 3 to 9,
AO is an oxyalkylene group having 3 to 4 carbon atoms, EO is an oxyethylene group, BO is an oxybutylene group, and the oxyalkylene group AO and the oxyethylene group EO and the oxybutylene group BO are optionally added in a block or random form, wherein when at least the oxyalkylene group AO and the oxybutylene group BO are added in a random form, AO is an oxypropylene group,
the average molar number p x l of addition of the oxyalkylene groups AO in the derivative satisfies 1.ltoreq.p x l.ltoreq.50,
the average molar number p x m of addition of the oxyethylene EO in the derivative satisfies 1.ltoreq.p x m.ltoreq.50,
the average addition mole number p multiplied by n of the oxybutylene groups BO in the derivative satisfies that p multiplied by n is more than or equal to 1 and less than or equal to 10,
The ratio m/(l+m) of the average addition mole number of the oxyethylene group EO to the total of the average addition mole number of the oxyalkylene group AO and the average addition mole number of the oxyethylene group EO is 0.15 to 0.75;
(b) An alkylene oxide derivative represented by the following formula (2),
R-[(PO) x (EO) y ] q -H…(2)
in the formula (2), the amino acid sequence of the compound,
r is a residue obtained by removing all hydroxyl groups from an alcohol having 2 to 3 carbon atoms,
q is the valence of the alcohol, is 2 or more and 3 or less,
PO is an oxypropylene group and the group,
EO is an oxyethylene group and the like,
the average addition mole number xxq of the oxypropylene group PO in the derivative satisfies 1.ltoreq.xxq.ltoreq.30,
the average molar number y x q of addition of the oxyethylene EO in the derivative satisfies 1.ltoreq.y x q.ltoreq.40,
the ratio y/(x+y) of the average addition mole number of the oxyethylene EO to the sum of the average addition mole number of the oxypropylene PO and the average addition mole number of the oxyethylene EO is 0.45-0.75,
the oxypropylene group PO and the oxyethylene group EO are added into a random shape;
(c) A polyhydric alcohol having 2 to 6 carbon atoms;
(d) And (3) water.
In addition, in order to solve the above-described technical problems, the inventors of the present application also thought whether the adhesion of a sunscreen cosmetic to skin and whitening can be improved by an emulsified cosmetic used before the application of the sunscreen cosmetic, not the sunscreen cosmetic itself. As a result of intensive studies by the inventors of the present application, the inventors of the present application have found that an emulsified cosmetic product comprising two specific alkylene oxide derivatives in combination with an oil agent and a nonionic surfactant at a specific ratio can thoroughly solve the above-mentioned problems.
Namely, the second invention is as follows.
An emulsified cosmetic composition comprising 0.1 to 25% by mass of the following component (a), 0.01 to 3% by mass of the following component (b), 1 to 50% by mass of the following component (e), 1 to 10% by mass of the following component (f) and the following component (g), wherein the mass ratio ((b)/(a)) of the component (b) to the component (a) is 1/100 to 1/5:
(a) Polyalkylene oxide derivatives represented by the following formula (1),
Z-[O(AO) l (EO) m (BO) n -H] p …(1)
in the formula (1), the components are as follows,
z is a residue obtained by removing all hydroxyl groups from an alcohol having 3 to 9 carbon atoms,
p is the valence of the alcohol, 3 to 9,
AO is an oxyalkylene group having 3 to 4 carbon atoms, EO is an oxyethylene group, BO is an oxybutylene group, and the oxyalkylene group AO and the oxyethylene group EO and the oxybutylene group BO are optionally added in a block or random form, wherein when at least the oxyalkylene group AO and the oxybutylene group BO are added in a random form, AO is an oxypropylene group,
the average molar number p x l of addition of the oxyalkylene groups AO in the derivative satisfies 1.ltoreq.p x l.ltoreq.50,
the average molar number p x m of addition of the oxyethylene EO in the derivative satisfies 1.ltoreq.p x m.ltoreq.50,
the average addition mole number p multiplied by n of the oxybutylene groups BO in the derivative satisfies that p multiplied by n is more than or equal to 1 and less than or equal to 10,
The ratio m/(l+m) of the average addition mole number of the oxyethylene group EO to the total of the average addition mole number of the oxyalkylene group AO and the average addition mole number of the oxyethylene group EO is 0.15 to 0.75;
(b) An alkylene oxide derivative represented by the following formula (2),
R-[(PO) x (EO) y ] q -H…(2)
in the formula (2), the amino acid sequence of the compound,
r is a residue obtained by removing all hydroxyl groups from an alcohol having 2 to 3 carbon atoms,
q is the valence of the alcohol, is 2 or more and 3 or less,
PO is an oxypropylene group and the group,
EO is an oxyethylene group and the like,
the average addition mole number xxq of the oxypropylene group PO in the derivative satisfies 1.ltoreq.xxq.ltoreq.30,
the average molar number y x q of addition of the oxyethylene EO in the derivative satisfies 1.ltoreq.y x q.ltoreq.40,
the ratio y/(x+y) of the average addition mole number of the oxyethylene EO to the sum of the average addition mole number of the oxypropylene PO and the average addition mole number of the oxyethylene EO is 0.45-0.75,
the oxypropylene group PO and the oxyethylene group EO are added into a random shape;
(e) Oiling agent;
(f) A nonionic surfactant;
(g) And (3) water.
Effects of the invention
According to the skin cosmetic of the first aspect of the present invention, the touch feeling is fresh and cool at the time of application, the moisturizing feeling after the mask is worn and removed for a long period of time is excellent, and the oily and sticky feeling of a person wearing oily skin after the mask can be suppressed for a long period of time.
The emulsified cosmetic for skin according to the second aspect of the present invention is excellent in touch feeling upon application, and can improve the adhesion of the sunscreen cosmetic applied on the basis of the above to the skin and can improve the whitening of the sunscreen cosmetic.
Detailed Description
The present invention will be described in detail below.
[ component (a) ]
Component (a) is an alkylene oxide derivative represented by formula (1), Z is an alcohol (Z (OH)) having 3 to 9 carbon atoms p ) The residues of all hydroxyl groups are removed, and p represents the valence of the alcohol and is 3-9.
When the alcohol (Z (OH) p ) When the number of carbon atoms of (2) is more than 9,since a sticky feeling is generated, it is 9 or less, preferably 8 or less, and more preferably 6 or less.
Furthermore, in the first invention, when alcohol (Z (OH) p ) When the number of carbon atoms is less than 3, the moist feeling is reduced, and thus is set to 3 or more.
Furthermore, in the second invention, when alcohol (Z (OH) p ) When the number of carbon atoms is less than 3, the adhesion of the sunscreen cosmetic is reduced, and thus is set to 3 or more.
Said alcohol (Z (OH) p ) Specifically, glycerol, trimethylolpropane, erythritol, pentaerythritol, sorbitan, alkyl glycoside, diglycerol, xylitol, dipentaerythritol, sorbitol, inositol, sucrose, trehalose, maltitol, and mixtures thereof are exemplified.
AO is an oxyalkylene group having 3 to 4 carbon atoms, and specifically includes oxypropylene group derived from oxypropylene, oxybutylene group derived from oxybutylene, and trimethylene oxide (oxytrimethylene group). The oxypropylene group and oxybutylene group are preferable, and the oxypropylene group is more preferable.
In the first invention, l is the average addition mole number of AO per hydroxyl group of the alkylene oxide derivative. Thus, the average molar number of addition of AO in the alkylene oxide derivative is p×l. If p×l is greater than 50, the refreshing feeling at the time of coating is impaired in the first invention, and the second invention is tacky at the time of coating, so that it is 50 or less, preferably 20 or less. When p×l is less than 1, the first invention gives rise to oily skin, and the second invention gives rise to a decrease in the adhesion of the sunscreen cosmetic, so that it is 1 or more, preferably 2 or more.
m is the average addition mole number of Ethylene Oxide (EO) per hydroxyl group of the alkylene oxide derivative. Thus, the average molar number of addition of AO in the alkylene oxide derivative is p×m. If p×m is greater than 50, a sticky feeling is generated, and therefore p×m is set to 50 or less, preferably 20 or less. If p×m is smaller than p×m, the moisturizing feeling after removal of the mask is impaired in the case of the first invention, and the adhesion of the sunscreen cosmetic is reduced in the case of the second invention, so that it is 1 or more, preferably 2 or more.
n is the average addition mole number of the oxybutylene (BO) groups per hydroxyl group of the alkylene oxide derivative.
The oxybutylene (BO) is oxybutylene derived from oxybutylene. If the average molar number p×n of BO added in the alkylene oxide derivative is less than 1, the refreshing feeling is poor in the case of the first invention, and the adhesion of the sunscreen cosmetic is poor in the case of the second invention, so that it is 1 or more. Further, if p×n is more than 10, a sticky feeling is generated, and therefore, it is 10 or less, preferably 5 or less.
The ratio "m/(l+m)" of the average addition mole number m of the oxyethylene group EO to the total (l+m) of the average addition mole number of the oxyalkylene group AO and the average addition mole number of the oxyethylene group EO is set to 0.15 to 0.75. When the ratio "m/(l+m)" is more than 0.75, a sticky feeling is generated, and thus, the ratio is set to 0.75 or less, preferably 0.72 or less, and more preferably 0.70 or less. If the ratio "m/(l+m)" is less than 0.15, the moisturizing feeling after removal of the mask is impaired in the case of the first invention, and the extent to which the sunscreen cosmetic is not whitened is impaired in the case of the second invention, so that it is 0.15 or more, preferably 0.30 or more, and more preferably 0.45 or more.
The order of addition of AO to EO and BO is not particularly limited, and may be either block-shaped or random-shaped. That is, AO, EO, and BO may all be added in a random form, or AO may be added in a block form, EO may be added in a block form, or BO may be added in a block form. The block-shaped portion and the random-shaped portion may be mixed. Wherein AO is an oxypropylene group when at least (AO) and (BO) are added in a random form. Here, when (AO) and (BO) are added in a random form, (EO) may be added in a random form together with (AO) and (BO), and (EO) may be added in a block form.
In particular, in a preferred embodiment, (BO) is added in the form of blocks. Furthermore, in particular in a preferred embodiment, AO is added to EO in a random fashion.
In formula (1), AO may be bonded to a terminal hydrogen atom, EO may be bonded to a terminal hydrogen atom, or BO may be bonded to a terminal hydrogen atom. In a preferred embodiment, BO is bound to a terminal hydrogen atom.
The alkylene oxide derivative of the formula (1) of the present invention can be produced by a known method.
Specifically, an Alkylene Oxide (AO), ethylene Oxide (EO), and Butylene Oxide (BO) having 3 to 4 carbon atoms are suitably subjected to addition polymerization with a compound having a hydroxyl group. The order of addition of the monomers in the addition polymerization is determined according to the target structure.
In a preferred embodiment, an Alkylene Oxide (AO) and Ethylene Oxide (EO) having 3 to 4 carbon atoms are addition polymerized with a compound having a hydroxyl group. In this case, AO and EO may be randomly polymerized, or AO may be block polymerized, or EO may be block polymerized. Then, after addition polymerization of AO and EO, BO is addition polymerized, whereby a BO block bonded to a terminal hydrogen atom can be produced.
[ component (b) ]
In the present invention, in the alkylene oxide derivative represented by the formula (2), R is an alcohol (R (OH)) having 1 to 3 carbon atoms q ) The residue having all hydroxyl groups removed, q represents the valence of the alcohol, and is 2 or more and 3 or less.
When the alcohol (R (OH) q ) If the number of carbon atoms is more than 3, a sticky feeling is produced.
In the present invention, in the alkylene oxide derivative represented by the formula (2), R is an alcohol (R (OH)) having 1 to 3 carbon atoms q ) The residue having all hydroxyl groups removed, q represents the valence of the alcohol, and is 2 or more and 3 or less.
PO is oxypropylene.
x is the average addition mole number of PO per hydroxyl group of the alkylene oxide derivative. The average molar number of addition of PO in the alkylene oxide derivative is qx. When q×x is less than 1, the first invention gives a shiny appearance to the skin, and the second invention gives a difference in the degree to which the sunscreen cosmetic does not whiten, and thus is 1 or more, more preferably 3 or more. In the first invention, when qx is larger than 30, the refreshing feeling at the time of application is impaired, and therefore, it is 30 or less, and more preferably 10 or less. In the second invention, if qx is greater than 30, the adhesive is formed, and therefore, the adhesive is 30 or less, preferably 25 or less, and more preferably 10 or less.
y is the average molar number of addition of EO per hydroxyl group of the alkylene oxide derivative. The average molar number of EO added in the alkylene oxide derivative is qxy. When qxy is more than 40, a sticky feeling is generated, and thus, it is 40 or less, preferably 35 or less, and more preferably 10 or less. When q×y is less than 1, the first invention is not particularly limited, and the first invention is preferably not less than 1, more preferably not less than 3, because the moisturizing feeling after removal of the mask is impaired, and the second invention is not particularly limited.
The ratio "y/(x+y)" of the average addition mole number of the oxyethylene group EO to the sum of the average addition mole number of the oxypropylene group PO and the average addition mole number of the oxyethylene group EO is set to 0.45 to 0.75. When "y/(x+y)" is more than 0.75, a sticky feeling is generated, and thus, it is set to 0.75 or less, preferably 0.70 or less, and more preferably 0.65 or less. In the first invention, if "y/(x+y)" is less than 0.15, the moist feeling after removal of the mask is impaired, and in the second invention, the adhesion of the sunscreen cosmetic is poor, so that it is 0.15 or more, preferably 0.30 or more, and more preferably 0.45 or more.
From the viewpoints of refreshing feel and no tackiness, the oxypropylene group PO and the oxyethylene group EO are added in a random form.
The alkylene oxide derivative of the formula (2) of the present invention can be produced by a known method. For example, the compound is obtained by reacting Propylene Oxide (PO) and Ethylene Oxide (EO) with a compound having a hydroxyl group.
[ component (c) ]
The polyhydric alcohol having 2 to 6 carbon atoms as the component (c) of the present invention is a water-soluble compound having two or more hydroxyl groups in the molecule, and examples thereof include propylene glycol, dipropylene glycol, isoprene glycol, 1, 3-butanediol, pentanediol, hexanediol, glycerol, diglycol, and the like. Water-soluble polyols having 2 to 3 carbon atoms are preferable, and glycerol and 1, 3-butanediol are particularly preferable.
[ component (d) ]
The component (d) of the present invention is water, and water generally used for cosmetics, medicines, and the like can be used. For example, ion-exchanged water, purified water, or the like can be used.
[ ratio of the Components in the first invention ]
In the first invention, the content of the component (a) is set to 0.1 to 25% by mass, when the total mass of the component (a), the component (b), the component (c) and the component (d) is set to 100% by mass. When the content of the component (a) is less than 0.1 mass%, the refreshing feeling is insufficient, and the moist feeling after removal of the mask is impaired, so that the content is set to 0.1 mass% or more, preferably 0.5 mass% or more, more preferably 1 mass% or more, and particularly preferably 2 mass% or more. Further, when the content of the component (a) is more than 25 mass%, the tackiness is long, and therefore, the content is 25 mass% or less, preferably 20 mass% or less, more preferably 15 mass% or less, and particularly preferably 10 mass% or less.
In the first invention, the content of the component (b) is set to 0.01 to 3 mass% when the total mass of the component (a), the component (b), the component (c) and the component (d) is set to 100 mass%. When the content of the component (b) is less than 0.01 mass%, the refreshing feeling is insufficient, and the moist feeling after removal of the mask is impaired, so that the content is set to 0.01 mass% or more. When the content of the component (b) is more than 3 mass%, the composition is tacky for a long period of time, and is therefore 3 mass% or less, preferably 2 mass% or less, and more preferably 0.5 mass% or less.
In the first invention, the content of the component (c) is set to 0.01 to 25 mass% when the total mass of the component (a), the component (b), the component (c) and the component (d) is set to 100 mass%. When the content of the component (c) is less than 0.01 mass%, the refreshing feeling is insufficient, and the moist feeling after removal of the mask is impaired, so that the content is set to 0.01 mass% or more, preferably 3.0 mass% or more. When the content of the component (c) is more than 25% by mass, the composition is tacky for a long time, and thus 25% by mass or less, more preferably 10% by mass or less.
The content of the component (d) is the remainder obtained by subtracting the total content of the component (a), the component (b) and the component (c) from 100 mass%.
In the first invention, the mass ratio ((b)/(a)) of the component (b) to the component (a) is set to 1/100 to 1/5. When ((b)/(a)) is less than 1/100, the skin produces a shiny appearance, and thus is set to 1/100 or more. When ((b)/(a)) is more than 1/5, the refreshing feeling is poor and the film is tacky for a long time, so that it is 1/5 or less, preferably 1/10, more preferably 1/50.
The cosmetic of the first invention may further contain other additive components in addition to the component (a), the component (b), the component (c) and the component (d). For example, the cosmetic of the first invention may preferably further contain the following component (h) in addition to the above components (a) to (d). Thereby, the effect of the present invention becomes further remarkable.
[ component (h) ]
The component (h) is a water-soluble thickener, and examples thereof include natural polysaccharides such as carrageenan, xanthan gum, dextrin, methylcellulose, hyaluronic acid, and chitosan; semisynthetic polysaccharides such as ethylcellulose, hydroxyethylcellulose and hydroxypropylcellulose; polyvinyl alcohol, polyacrylic acid, polymethacrylic acid, carboxyvinyl polymer, acrylic acid/alkyl acrylate (having 10 to 30 carbon atoms) copolymer, and the like. Among them, xanthan gum, hydroxypropyl methylcellulose, carboxyvinyl polymers, and acrylic acid/alkyl acrylate (having 10 to 30 carbon atoms) copolymers are preferable from the viewpoint of keeping the makeup or not sticking.
When the component (h) is contained in the skin cosmetic of the first invention, the content of the component (h) is preferably 0.01 to 5% by mass, more preferably 0.05 to 4% by mass, and even more preferably 0.1 to 3% by mass, based on 100% by mass of the total amount of the cosmetic.
In addition to the components (a) to (d) (and optionally further component (h)) within a range where the effects of the present invention are not lost, other components may be added to the skin cosmetic of the first invention. As other optional components, alcohols, saccharides, polysaccharides, amino acids, various surfactants, organic salts, inorganic salts, pH adjusters, chelating agents, antioxidants, bactericides, blood flow promoters, anti-inflammatory agents, ultraviolet absorbers, ultraviolet scattering agents, vitamins, pigments, perfumes, and the like can be blended appropriately.
[ component (e) ]
The oil (component (e)) used in the second invention may be used as an oil usable for general cosmetics, and examples thereof include hydrocarbon oils, ester oils, vitamins, hormones, whitening agents, anti-inflammatory and antihistamines, antioxidants, intercellular lipids, ultraviolet absorbers, various moisturizers, and various fragrances.
Examples of hydrocarbon oils include liquid paraffin, polybutene, hydrogenated polyisobutene, hydrogenated polydecene, squalane, squalene, pristane, light isoparaffin, light liquid isoparaffin, heavy liquid isoparaffin, tetradecene, isohexadecane, isododecane, α -olefin oligomer, vaseline, microcrystalline wax, paraffin, polyethylene, ceresin (ceresin), and the like.
The ester oil is an oil agent having an ester group, and examples thereof include triglycerides and fats of fatty acids and glycerol, and further examples thereof include esters of amino acids or fatty acids with monovalent or higher alcohols.
Examples of the triglyceride include triglycerides of fatty acids such as caproic acid, caprylic acid, capric acid, 2-ethylhexanoic acid, lauric acid, tridecanoic acid, isotridecanoic acid, myristic acid, palmitic acid, isopalmitic acid, stearic acid, isostearic acid, eicosanoic acid, behenic acid, lignoceric acid, myristoleic acid, palmitoleic acid, oleic acid, elaidic acid, erucic acid, linoleic acid, linolenic acid, arachidonic acid, hydroxystearic acid, coconut oil fatty acid, palm kernel oil fatty acid, hydrogenated palm kernel oil fatty acid, palm oil fatty acid, tallow fatty acid, hydrogenated tallow fatty acid, lard fatty acid, castor oil fatty acid, and hydrogenated castor oil fatty acid, and glycerol.
Examples of the oils include oils and fats such as olive oil, sunflower oil, palm kernel oil, safflower oil, castor oil, hydrogenated castor oil, coconut oil, camellia oil, cocoa butter, and shea butter.
Examples of the ester of an amino acid with a monovalent or higher alcohol include dihexyl decyl lauroyl glutamate, diisostearyl lauroyl glutamate, bis (hexyldecyl/octyldodecyl) lauroyl glutamate, dioctyl dodecyl stearoyl glutamate, plant sterol myristoylmethyl β -aminopropionate, cholesterol/behenyl/2-octyldodecyl lauroyl glutamate, plant sterol/behenyl/2-octyldodecyl lauroyl glutamate, cholesterol/2-octyldodecyl lauroyl glutamate, plant sterol/2-octyldodecyl lauroyl glutamate, and plant sterol/behenyl/2-octyldodecyl/isostearyl lauroyl glutamate.
As the ester of a fatty acid with an alcohol having a valence of more than one, examples thereof include ethyl oleate, ethyl linoleate, isopropyl myristate, isopropyl palmitate, isopropyl isostearate, isopropyl lanolate, cetyl ethylhexanoate, isocetyl ethylhexanoate, stearyl ethylhexanoate, isostearyl ethylhexanoate, cetyl palmitate, 2-ethylhexyl palmitate, 2-hexyldecyl isostearate, isostearyl isostearate, trimethylolpropane triisostearate, myristyl myristate, cetyl myristate, octyldodecyl myristate, isostearyl myristate, isocetyl myristate, hexyl laurate, decyl oleate, octyldodecyl oleate, isostearyl pivalate, isopropyl isostearate, isononyl isononanoate, 2-ethylhexyl isononanoate, isodecyl isononanoate, and the like Isodecanol isononanoate, octyldodecanol erucate, neopentyl glycol dicaprate, pentaerythritol tetra (2-ethylhexanoate), diisostearyl malate, didecyl adipate, glycerol isostearate, hydrogenated castor oil isostearate, cholesterol isostearate, squalyl isostearate, phytosterol isostearate, ethylhexyl hydroxystearate, dihydrocholeoleate, phytosterol oleate, hydrogenated castor oil stearate, cholesteryl lanolate, cholesteryl hydroxystearate, dipentaerythritol hexahydroxystearate, hydrogenated castor oil monohydroxystearate, isostearyl lanolate, isopropyl lanolate, octyldodecanol lanolate, cholesteryl stearate, cholesteryl lanolate, cetyl ricinoleate, dioctyl succinate, cetyl lactate, propylene glycol dicaprylate, propylene glycol dicaprate/dicaprate, propylene glycol distearate, propylene glycol diisostearate, propylene glycol dioleate, and the like. In addition, waxes such as beeswax, wood wax, carnauba wax, lanolin, candelilla wax, and jojoba oil can also be used.
As the ester oil, one kind or two or more kinds of them can be used singly or in combination.
Preferable ester oils include, for example, triglycerides of fatty acids having 6 or more carbon atoms, oils, cetyl ethylhexanoate, isocetyl ethylhexanoate, isopropyl palmitate, 2-ethylhexyl palmitate, isopropyl isostearate, 2-hexyldecyl isostearate, octyldodecyl myristate, isopropyl myristate, isostearyl myristate, isocetyl myristate, isononyl isononanoate, 2-ethylhexyl isononanoate, isodecyl isononanoate, isotridecyl isononanoate, beeswax, wood wax, plant sterol myristoylmethyl β -aminopropionate, cholesterol/behenyl/2-octyldodecyl lauroyl glutamate, phytosterol/2-octyldodecyl lauroyl glutamate, and phytosterol/2-octyldodecyl/isostearyl lauroyl glutamate.
Examples of vitamins include vitamin a and its derivatives, vitamin B2 fat-soluble derivatives, vitamin B6 fat-soluble derivatives, vitamin C amphiphilic derivatives such as trisodium ascorbyl palmitate phosphate, vitamin E and its derivatives such as vitamin D, tocopherol or tocopheryl acetate, vitamin H, pantothenic acid fat-soluble derivatives, coenzyme Q10 (vitamin Q), and the like.
Examples of hormones include cortisone, hydrocortisone, estradiol, and estrone.
Examples of the whitening agent include kojic acid, placenta extract, arbutin, ellagic acid, 4-n-butylresorcinol (rucinol), and linoleic acid.
Examples of the anti-inflammatory agent and antihistamine include glycyrrhetinic acid and its derivatives, glycyrrhizic acid and its derivatives, allantoin, hydrocortisone acetate, and prednisolone.
Examples of antioxidants (anti-aging agents) include antioxidants such as polyphenols, carotenoids, flavonoids, and the like; N-methyl-L-serine, ursolic acid, etc.
Examples of the intercellular lipids include ceramide and cholesterol.
Examples of the ultraviolet absorbers include p-aminobenzoic acid derivatives, cinnamic acid derivatives, benzophenone derivatives, and salicylic acid derivatives.
Examples of the moisturizing agent include hyaluronic acid derivatives, collagen derivatives, elastin derivatives, keratin derivatives, and the like.
Examples of the perfume include various plant extracts and limonene.
One or two or more of these oily components may be used singly or in combination.
[ component (f) ]
Component (f) is a nonionic surfactant commonly used in cosmetics.
The HLB of the component (f) is preferably 2 to 16.HLB is an abbreviation of Hyrobile-Lipophile Balance (hydrophilic-lipophilic balance) and is a concept obtained by digitizing the balance between hydrophilic groups and lipophilic groups of a surfactant. Generally, the higher the number, the higher the hydrophilicity, expressed in 0 to 20. The calculation of HLB is calculated by any one of the following formulas advocated by Griffin.
POE alkyl ether type: HLB = weight fraction of oxyethylene groups/5
Polyol fatty acid ester type and polyglycerol type nonionic surfactant: hlb=20 (1-S/a), S: saponification number of ester, a: acid value of fatty acid (origin: new version of surfactant handbook engineering book Co., ltd.)
Examples of the component (f) include glycerin fatty acid ester, sorbitan fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene alkyl ether, and polyoxyalkylene fatty acid ester. One or two or more selected from them can be used. Among these, one or more nonionic surfactants having an HLB of less than 10 are preferably combined with one or more nonionic surfactants having an HLB of 10 or more. The reason for this is that an effect of excellent emulsion stability is achieved. Examples of the nonionic surfactant having an HLB of less than 10 include glycerin monostearate and sorbitan monostearate. Examples of the nonionic surfactant having an HLB of 10 or more include polyoxyethylene (20) sorbitan monostearate.
The blending ratio of the nonionic surfactant having an HLB of less than 10 to the nonionic surfactant having an HLB of 10 or more is 1:10 to 10:1 by weight, more preferably 1:5 to 5:1. When the amount of the nonionic surfactant having an HLB of less than 10 is less than 0.1 times the amount of the nonionic surfactant having an HLB of 10 or more than 10 times the amount of the nonionic surfactant having an HLB of 10 or more, the emulsion stability is poor. Examples of the commercial products of the component (f) include glycerin monostearate (HLB; 3.0) (SUNSOFT No.2500-C manufactured by Taiyo Kagaku Co., ltd.), polyoxyethylene (20 moles) sorbitan monostearate (HLB; 14.9) (TOHO Chemical Industry Co., ltd. "SORBON T-60") and the like.
[ component (g) ]
The component (g) of the second invention is water, and water generally used for cosmetics, medicines, and the like can be used. For example, ion-exchanged water, purified water, or the like can be used.
(component ratio in the second invention)
In the second aspect of the present invention, the content of the component (a) is set to 0.1 to 25% by mass, based on 100% by mass of the total mass of the component (a), the component (b), the component (e), the component (f) and the component (g). When the content of the component (a) is less than 0.1% by mass, the adhesion and the degree of non-whitening of the sunscreen cosmetic are insufficient, and thus 0.1% by mass or more, preferably 0.5% by mass or more, more preferably 1% by mass or more, and particularly preferably 2% by mass or more. Further, when the content of the component (a) is more than 25 mass%, the tackiness is long, and therefore, the content is 25 mass% or less, preferably 20 mass% or less, more preferably 15 mass% or less, and particularly preferably 10 mass% or less.
In the second aspect of the present invention, the content of the component (b) is set to 0.01 to 3% by mass, based on 100% by mass of the total mass of the component (a), the component (b), the component (e), the component (f) and the component (g). When the content of the component (b) is less than 0.01 mass%, the adhesion of the sunscreen cosmetic is insufficient, and thus is set to 0.01 mass% or more. When the content of the component (b) is more than 3 mass%, the composition is tacky for a long period of time, and is therefore 3 mass% or less, preferably 2 mass% or less, and more preferably 0.5 mass% or less.
In the second aspect of the present invention, the content of the component (e) is set to 1 to 50% by mass, based on 100% by mass of the total mass of the component (a), the component (b), the component (e), the component (f) and the component (g). When the content of the component (e) is less than 1% by mass, the degree of adhesion and non-whitening of the sunscreen cosmetic is insufficient, and thus 1% by mass or more, preferably 3% by mass or more, and more preferably 10% by mass or more. When the content of the component (e) is more than 50% by mass, the composition is tacky for a long period of time, and thus is 50% by mass or less, preferably 30% by mass or less, and more preferably 20% by mass or less.
In the second aspect of the present invention, the content of the component (f) is 1 to 10% by mass, based on 100% by mass of the total mass of the component (a), the component (b), the component (e), the component (f) and the component (g). When the content of the component (f) is less than 1% by mass, the adhesion of the sunscreen cosmetic is insufficient, and thus 1% by mass or more, preferably 2% by mass or more, and more preferably 4% by mass or more. When the content of the component (f) is more than 10 mass%, the composition is tacky for a long time, and thus is 10 mass% or less, preferably 8 mass% or less, and more preferably 6 mass% or less.
The content of the component (g) is the remainder obtained by subtracting the total content of the component (a), the component (b), the component (e) and the component (f) from 100 mass%.
In the present invention, the mass ratio ((b)/(a)) of the component (b) to the component (a) is set to 1/100 to 1/5. When ((b)/(a)) is less than 1/100, the adhesion of the sunscreen cosmetic is poor, and thus 1/100 or more. Further, since the adhesive is tacky when ((b)/(a)) is more than 1/5, it is 1/5 or less, preferably 1/10, more preferably 1/50.
In addition to the components (a), (b) and (e) to (g), other components may be further added to the emulsified cosmetic composition of the second invention within a range where the effects of the invention are not impaired. As other optional components, alcohols, saccharides, polysaccharides, amino acids, various surfactants, organic salts, inorganic salts, pH adjusters, chelating agents, antioxidants, bactericides, blood flow promoters, anti-inflammatory agents, ultraviolet absorbers, ultraviolet scattering agents, vitamins, pigments, perfumes, and the like can be blended appropriately.
Examples
Hereinafter, the present invention will be described in more detail with reference to examples and comparative examples, but the present invention is not limited thereto.
(embodiment of the first invention)
Synthesis examples a1, a2, a3, a '1, a'2, a '3, a'4
1 mol of the alcohol shown in Table 1 and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the alkylene oxide derivative were added to the autoclave, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110℃with stirring. Next, a mixed solution of p×l moles of propylene oxide and p×m moles of ethylene oxide was dropped from the dropping apparatus using the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out at 110℃for 3 hours. Then, p×n moles of butene oxide were added dropwise from the dropping apparatus into the autoclave. After the completion of the dropwise addition, the reaction was carried out at 110℃for 2 hours. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt generated by dehydration, the compounds of synthesis examples a1, a2, a3, a '1, a'2, a '3, a'4 were obtained by filtration.
Synthesis example a4
To the autoclave were added 1 mol of glycerol and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the alkylene oxide derivative, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110 ℃ while stirring. Next, a mixed solution of 3 moles of butene oxide and 3 moles of ethylene oxide was dropped from the dropping apparatus using the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out at 110℃for 3 hours. Then, 1.5 mol of butene oxide was added dropwise from the dropping apparatus into the autoclave. After the completion of the dropwise addition, the reaction was carried out at 110℃for 2 hours. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt formed by dehydration, filtration was performed to obtain the compound of synthesis example a 4.
Synthesis example a5
1 mol of sucrose and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the alkylene oxide derivative were added to the autoclave, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110℃with stirring. Next, 48 moles of propylene oxide was added dropwise from the dropping apparatus using the dropping apparatus. The reaction was carried out for 2 hours after the completion of the dropwise addition. Then, 10 moles of ethylene oxide was added dropwise from the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out at 110℃for 1 hour. Then, 8 moles of butene oxide was added dropwise from the dropping apparatus into the autoclave. After the completion of the dropwise addition, the reaction was carried out at 110℃for 2 hours. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt formed by dehydration, filtration was performed to obtain the compound of synthesis example a 5.
Synthesis examples b1, b2 and b3
1 mol of the alcohol shown in Table 2 and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the alkylene oxide derivative were added to the autoclave, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110℃with stirring. Next, a mixed solution of q×x moles of propylene oxide and q×y moles of ethylene oxide was dropped from the dropping apparatus using the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out at 110℃for 3 hours. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt produced by dehydration, filtration was performed to obtain the compounds of synthesis examples b1, b2, and b 3.
Synthesis example b'1
1 mol of sorbitol and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the alkylene oxide derivative were added to the autoclave, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110℃with stirring. Next, 12 moles of propylene oxide was added dropwise from the dropping apparatus using the dropping apparatus. The reaction was carried out for 2 hours after the completion of the dropwise addition. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt formed by dehydration, filtration was performed to obtain the compound of synthesis example b' 1.
Synthesis example b'2
To the autoclave were added 1 mol of glycerol and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the ethylene oxide derivative, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110 ℃ while stirring. Next, 12 moles of ethylene oxide was added dropwise from the dropping apparatus using the dropping apparatus. The reaction was carried out for 2 hours after the completion of the dropwise addition. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt formed by dehydration, filtration was performed to obtain the compound of synthesis example b' 2.
Preparation method of evaluation cosmetic
(1) When arginine is used, a 10% aqueous solution is prepared in advance.
(2) While mixing the component (d) (ion-exchanged water) with a dispersing mixer, the component (c) was gradually added in small amounts and dissolved.
(3) Then, the component (a) or (a '), the component (b) or (b'), and other components are added and stirred until uniform.
< evaluation method >)
The use feeling test was performed on 20 men who self-felt oily skin. 1.0g of the prepared cosmetic was taken in the hand and applied to the entire face, and for the following 4 items, 4-grade evaluations of 0 to 3 points were performed by each tester by the following absolute evaluation.
(1) Fresh feel during coating
(2) Wearing mask for 6 hours after coating, and picking up moistening feeling after 5 minutes
(3) Skin oil after wearing mask for 6 hours after coating
(4) Degree of non-tackiness after wearing mask for 6 hours after coating
For each item, 5 grades from AA to D were classified based on the total of the scores, and AA, a, and B were qualified.
Further, for the evaluation after wearing the masks of (2), (3) and (4), a pleated nonwoven fabric mask (material: polypropylene, manufactured by Tamagawa-Eizai co., ltd.) was used, and the evaluation was carried out after being worn in a room at 25 ℃ and humidity of 70% rh for 6 hours.
< final evaluation based on the aggregate of absolute scores >
AA: the total score is 50 to 60 points
A: the total score is 40 to 49 points
B: the total score is 30 to 39 points
C: the total of the scores is 20 to 29 points
D: the total of the scores is less than 20 points
(1) Fresh feel during coating
(absolute evaluation criterion)
(score): (evaluation)
3: the refreshing feeling at the time of coating is excellent
2: the coating gives a good refreshing feel
1: hardly feel refreshing feeling at the time of coating
0: no refreshing feeling at the time of coating is felt at all
(2) Wearing mask for 6 hours after coating, and picking up moistening feeling after 5 minutes
(absolute evaluation criterion)
(score): (evaluation)
3: excellent moisturizing feeling
2: good sense of moisture
1: hardly feel moist
0: the sense of moistening is not felt at all
(3) Skin oil after wearing mask for 6 hours after coating
(score): (evaluation)
3: no oily light is felt at all
2: hardly feel oily light
1: how much can feel oily light
0: can feel oily light
(4) Degree of tack-free after 6 hours of wearing mask after coating
(score): (evaluation)
3: no stickiness is felt at all
2: hardly felt sticky
1: how much can feel tacky
0: can feel sticky
Examples 1 to 6 and comparative examples 1 to 11 >
Cosmetics were prepared and evaluated by the above method. The formulations and results are shown in tables 3, 4, and 5. In addition, all formulations were prepared in an amount of 100 g.
/>
TABLE 3
TABLE 3 Table 3
TABLE 4
TABLE 4 Table 4
TABLE 5
TABLE 5
As shown in table 3, in examples 1 to 6, the touch feeling was fresh at the time of application, the moist feeling after the mask was worn for a long time and removed was excellent, and the oily and sticky feeling of the person wearing the oily skin after the mask was able to be suppressed for a long time.
On the other hand, in comparative examples 1 to 11, no sufficient effect was obtained.
That is, in comparative examples 1 to 4, the effect of the present invention was not satisfied at the same time because the comparative component (a') having a structure outside the range of the component (a) of the present invention was included.
In comparative examples 5 and 6, the effect of the present invention was not satisfied at the same time because the comparative component (b') having a structure outside the range of the component (b) of the present invention was included.
In comparative example 7, the component (b) was not contained, and therefore, the refreshing feeling at the time of application, the moist feeling after removal of the mask, and the degree of non-tackiness after wearing the mask were poor.
In comparative example 8, b/a was greater than 1/5, so that the feeling of freshness at the time of application, the feeling of moisturization after removal of the mask, and the degree of non-tackiness after wearing the mask were poor.
In comparative example 9, the contents of the component (a) and the component (b) were 25 mass% and were each more than 3 mass%, so that all effects were insufficient.
In comparative example 10, the component (a) was not contained, so that the refreshing feeling at the time of application, the moist feeling after removal of the mask, and the degree of non-tackiness after wearing the mask were poor.
In comparative example 11, the component (c) was not contained, and therefore, the refreshing feeling at the time of application, the moist feeling after removal of the mask, and the degree of no oily light after wearing the mask were poor.
(embodiment of the second invention)
Synthesis examples a1, a2, a3, a '1, a'2, a '3, a'4
1 mol of the alcohol shown in Table 6 and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the alkylene oxide derivative were added to the autoclave, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110℃with stirring. Next, a mixed solution of p×l moles of propylene oxide and p×m moles of ethylene oxide was dropped from the dropping apparatus using the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out at 110℃for 3 hours. Then, p×n moles of butene oxide were added dropwise from the dropping apparatus into the autoclave. After the completion of the dropwise addition, the reaction was carried out at 110℃for 2 hours. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt generated by dehydration, the compounds of synthesis examples a1, a2, a3, a '1, a'2, a '3, a'4 were obtained by filtration.
Synthesis example a4
To the autoclave were added 1 mol of glycerol and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the alkylene oxide derivative, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110 ℃ while stirring. Next, a mixed solution of 3 moles of butene oxide and 3 moles of ethylene oxide was dropped from the dropping apparatus using the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out at 110℃for 3 hours. Then, 1.5 mol of butene oxide was added dropwise from the dropping apparatus into the autoclave. After the completion of the dropwise addition, the reaction was carried out at 110℃for 2 hours. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt formed by dehydration, filtration was performed to obtain the compound of synthesis example a 4.
Synthesis example a5
1 mol of sucrose and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the alkylene oxide derivative were added to the autoclave, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110℃with stirring. Next, 48 moles of propylene oxide was added dropwise from the dropping apparatus using the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out for 2 hours. Then, 10 moles of ethylene oxide was added dropwise from the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out at 110℃for 1 hour. Then, 8 moles of butene oxide was added dropwise from the dropping apparatus into the autoclave. After the completion of the dropwise addition, the reaction was carried out at 110℃for 2 hours. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt formed by dehydration, filtration was performed to obtain the compound of synthesis example a 5.
Synthesis examples b1, b2 and b3
1 mol of the alcohol shown in Table 7 and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the alkylene oxide derivative were added to the autoclave, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110℃with stirring. Next, a mixed solution of q×x moles of propylene oxide and q×y moles of ethylene oxide was dropped from the dropping apparatus using the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out at 110℃for 3 hours. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt produced by dehydration, filtration was performed to obtain the compounds of synthesis examples b1, b2, and b 3.
Synthesis example b'1
1 mol of sorbitol and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the alkylene oxide derivative were added to the autoclave, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110℃with stirring. Next, 12 moles of propylene oxide was added dropwise from the dropping apparatus using the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out for 2 hours. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt formed by dehydration, filtration was performed to obtain the compound of synthesis example b' 1.
Synthesis example b'2
To the autoclave were added 1 mol of glycerol and 0.1 mass% of potassium hydroxide as a catalyst relative to the final weight of the ethylene oxide derivative, and after replacing the air in the autoclave with dry nitrogen, the catalyst was completely dissolved at 110 ℃ while stirring. Next, 12 moles of ethylene oxide was added dropwise from the dropping apparatus using the dropping apparatus. After the completion of the dropwise addition, the reaction was carried out for 2 hours. Then, the reaction product was taken out of the autoclave and neutralized with hydrochloric acid to a pH of 6 to 7, and dehydrated at-0.095 MPa (50 mmHg) and 100℃for 1 hour to remove the water contained therein. Further, in order to remove the neutralized salt formed by dehydration, filtration was performed to obtain the compound of synthesis example b' 2.
Preparation method of emulsion cosmetic
(1) The oil phase composed of the behenyl alcohol in component (e), component (f) and the common component was mixed with the aqueous phase composed of the propylene glycol, glycerol and water (component (g)) in the common component at 80 ℃.
(2) The oil phase prepared in (1) was mixed with the water phase (3000 rpm, 5 minutes) at 80℃using a homomixer.
(3) The mixture was cooled, then component (a) and component (b) were added to the mixture, and stirred until uniform.
< evaluation method >)
20 professional testers were allowed to conduct the use sense test. 0.5g of the prepared emulsified cosmetic was applied to the face by hand, and the following absolute evaluation was made by each tester and evaluated on 4 grades of 0 to 3, with respect to (1) the degree of non-tackiness at the time of application, (2) the adhesiveness of the sunscreen cosmetic, and (3) the degree of non-whitening of the sunscreen cosmetic. Further, the scores were classified into 5 grades of AA to D based on the total of the scores, and AA, a, and B were qualified.
< final evaluation based on the aggregate of absolute scores >
AA: the total score is 50 to 60 points
A: the total score is 40 to 49 points
B: the total score is 30 to 39 points
C: the total of the scores is 20 to 29 points
D: the total of the scores is less than 20 points
(1) Degree of non-tackiness upon coating
The degree of tackiness at the time of applying the prepared emulsified cosmetic to the face and allowing it to fuse was evaluated by sensory evaluation and according to the following evaluation criteria.
(absolute evaluation criterion)
(score): (evaluation)
3: coating is not sticky
2: the coating is not sticky
1: slightly felt tacky on application
0: feel tacky when applied
(2) Adhesion of sunscreen cosmetics
After the prepared emulsified cosmetic was applied to the face and allowed to adhere, 0.5g of a commercially available sunscreen cosmetic (Shiseido Company, limited, anessa Perfect UV skin care milk N) was applied, and the adhesion of the sunscreen cosmetic to the face (the degree of adhesion) was evaluated according to the following criteria.
(absolute evaluation criterion)
(score): (evaluation)
3: excellent adhesion (good degree of adhesion)
2: good adhesion (good degree of bonding)
1: almost no adhesion (good degree of adhesion) was perceived
0: no adhesion was felt at all (good degree of fitting)
(3) Degree of non-whitening of sunscreen cosmetics
The emulsified cosmetic thus prepared was visually evaluated for whitening (blushing) when 0.5g of a commercially available sunscreen cosmetic (Shiseido Company, limited, anessa Perfect UV skin care milk N) was applied to the face and allowed to adhere thereto according to the following criteria.
(score): (evaluation)
3: no blushing at all
2: hardly see blushing
1: how much is seen as blushing
0: see whitening of
Examples 1 to 6 and comparative examples 1 to 11 >
Cosmetics were prepared and evaluated by the above method. The formulations and results are shown in tables 8, 9 and 10. In addition, all formulations were prepared in an amount of 100 g.
/>
TABLE 10
Table 10
Examples 1 to 6 were all excellent in the degree of adhesion of a sunscreen cosmetic and whitening of a sunscreen cosmetic, without being sticky at the time of application.
On the other hand, in comparative examples 1 to 13, no sufficient effect was obtained.
That is, in comparative examples 1 to 4, the effect of the present invention was not satisfied at the same time because the comparative component (a') having a structure outside the range of the component (a) of the present invention was included.
In comparative examples 5 and 6, the effect of the present invention was not satisfied at the same time because the comparative component (b') having a structure outside the range of the component (b) of the present invention was included.
In comparative example 7, since the component (b) was not contained, the adhesion of the sunscreen cosmetic was low.
In comparative example 8, since (b/a) was more than 1/5, it was sticky.
In comparative example 9, the contents of the component (a) and the component (b) were 25% by mass, respectively, and were all greater than 3% by mass, and thus were tacky.
In comparative example 10, the effect of the present invention was not satisfied at the same time because the component (a) was not contained.
In comparative example 11, the component (e) and the component (f) were not contained, and therefore, the adhesion and the non-whitening degree of the sunscreen cosmetic were poor.
In comparative example 12, the component (e) was not contained, and therefore, the degree of non-tackiness at the time of application and the degree of non-whitening of the sunscreen cosmetic were poor.
In example 2, the ratio of component (f) was set to 0, and as a result, the components were separated, and an emulsified cosmetic could not be prepared.
Claims (2)
1. A skin cosmetic comprising 0.1 to 25% by mass of the following component (a), 0.01 to 3% by mass of the following component (b), 0.1 to 25% by mass of the following component (c) and the following component (d), wherein the mass ratio ((b)/(a)) of the component (b) to the component (a) is 1/100 to 1/5:
(a) Polyalkylene oxide derivatives represented by the following formula (1),
Z-[O(AO) l (EO) m (BO) n -H] p …(1)
in the formula (1), the components are as follows,
z is a residue obtained by removing all hydroxyl groups from an alcohol having 3 to 9 carbon atoms,
p is the valence of the alcohol, 3 to 9,
AO is an oxyalkylene group having 3 to 4 carbon atoms, EO is an oxyethylene group, BO is an oxybutylene group, and the oxyalkylene group AO and the oxyethylene group EO and the oxybutylene group BO are optionally added in a block or random form, wherein when at least the oxyalkylene group AO and the oxybutylene group BO are added in a random form, AO is an oxypropylene group,
the average molar number p x l of addition of the oxyalkylene groups AO in the derivative satisfies 1.ltoreq.p x l.ltoreq.50,
the average molar number p x m of addition of the oxyethylene EO in the derivative satisfies 1.ltoreq.p x m.ltoreq.50,
the average addition mole number p multiplied by n of the oxybutylene groups BO in the derivative satisfies that p multiplied by n is more than or equal to 1 and less than or equal to 10,
the ratio m/(l+m) of the average addition mole number of the oxyethylene group EO to the total of the average addition mole number of the oxyalkylene group AO and the average addition mole number of the oxyethylene group EO is 0.15 to 0.75;
(b) An alkylene oxide derivative represented by the following formula (2),
R-[(PO) x (EO) y ] q -H…(2)
in the formula (2), the amino acid sequence of the compound,
R is a residue obtained by removing all hydroxyl groups from an alcohol having 2 to 3 carbon atoms,
q is the valence of the alcohol, is 2 or more and 3 or less,
PO is an oxypropylene group and the group,
EO is an oxyethylene group and the like,
the average addition mole number xxq of the oxypropylene group PO in the derivative satisfies 1.ltoreq.xxq.ltoreq.30,
the average molar number y x q of addition of the oxyethylene EO in the derivative satisfies 1.ltoreq.y x q.ltoreq.40,
the ratio y/(x+y) of the average addition mole number of the oxyethylene EO to the sum of the average addition mole number of the oxypropylene PO and the average addition mole number of the oxyethylene EO is 0.45-0.75,
the oxypropylene group PO and the oxyethylene group EO are added into a random shape;
(c) A polyhydric alcohol having 2 to 6 carbon atoms;
(d) And (3) water.
2. An emulsified cosmetic composition comprising 0.1 to 25% by mass of the following component (a), 0.01 to 3% by mass of the following component (b), 1 to 50% by mass of the following component (e), 1 to 10% by mass of the following component (f) and the following component (g), wherein the mass ratio ((b)/(a)) of the component (b) to the component (a) is 1/100 to 1/5:
(a) Polyalkylene oxide derivatives represented by the following formula (1),
Z-[O(AO) l (EO) m (BO) n -H] p …(1)
in the formula (1), the components are as follows,
Z is a residue obtained by removing all hydroxyl groups from an alcohol having 3 to 9 carbon atoms,
p is the valence of the alcohol, 3 to 9,
AO is an oxyalkylene group having 3 to 4 carbon atoms, EO is an oxyethylene group, BO is an oxybutylene group, and the oxyalkylene group AO and the oxyethylene group EO and the oxybutylene group BO are optionally added in a block or random form, wherein when at least the oxyalkylene group AO and the oxybutylene group BO are added in a random form, AO is an oxypropylene group,
the average molar number p x l of addition of the oxyalkylene groups AO in the derivative satisfies 1.ltoreq.p x l.ltoreq.50,
the average molar number p x m of addition of the oxyethylene EO in the derivative satisfies 1.ltoreq.p x m.ltoreq.50,
the average addition mole number p multiplied by n of the oxybutylene groups BO in the derivative satisfies that p multiplied by n is more than or equal to 1 and less than or equal to 10,
the ratio m/(l+m) of the average addition mole number of the oxyethylene group EO to the total of the average addition mole number of the oxyalkylene group AO and the average addition mole number of the oxyethylene group EO is 0.15 to 0.75;
(b) An alkylene oxide derivative represented by the following formula (2),
R-[(PO) x (EO) y ] q -H…(2)
in the formula (2), the amino acid sequence of the compound,
r is a residue obtained by removing all hydroxyl groups from an alcohol having 2 to 3 carbon atoms,
q is the valence of the alcohol, is 2 or more and 3 or less,
PO is an oxypropylene group and the group,
EO is an oxyethylene group and the like,
the average addition mole number xxq of the oxypropylene group PO in the derivative satisfies 1.ltoreq.xxq.ltoreq.30,
the average molar number y x q of addition of the oxyethylene EO in the derivative satisfies 1.ltoreq.y x q.ltoreq.40,
the ratio y/(x+y) of the average addition mole number of the oxyethylene EO to the sum of the average addition mole number of the oxypropylene PO and the average addition mole number of the oxyethylene EO is 0.45-0.75,
the oxypropylene group PO and the oxyethylene group EO are added into a random shape;
(e) Oiling agent;
(f) A nonionic surfactant;
(g) And (3) water.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022-135552 | 2022-08-29 | ||
JP2022156320A JP2024049841A (en) | 2022-09-29 | 2022-09-29 | Emulsified cosmetics |
JP2022-156320 | 2022-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117618285A true CN117618285A (en) | 2024-03-01 |
Family
ID=90030979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311057622.3A Pending CN117618285A (en) | 2022-08-29 | 2023-08-22 | Skin cosmetic and emulsified cosmetic |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2024049841A (en) |
CN (1) | CN117618285A (en) |
-
2022
- 2022-09-29 JP JP2022156320A patent/JP2024049841A/en active Pending
-
2023
- 2023-08-22 CN CN202311057622.3A patent/CN117618285A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2024049841A (en) | 2024-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101044196B1 (en) | Water-in-oil emulsion cosmetic composit ion | |
JP5101808B2 (en) | Oil-in-water liquid composition | |
BRPI0710233A2 (en) | aqueous film composition, dermatologically acceptable film, and method for delivering an active agent to the epidermis | |
JP5720997B2 (en) | Oil-in-water cosmetic | |
KR20120022822A (en) | External preparation for skin | |
JP7058943B2 (en) | Oil-in-water emulsification composition | |
US9757322B2 (en) | Liquid cosmetic | |
JP5720998B2 (en) | Cosmetic base and cosmetic comprising the same | |
JP5053562B2 (en) | Emulsified cosmetics | |
JP3780257B2 (en) | Dermal composition for oil and fat suppression | |
JP5906839B2 (en) | Cosmetics | |
JP2002068934A (en) | Water-in-oil type emulsion composition | |
CN117618285A (en) | Skin cosmetic and emulsified cosmetic | |
WO2019188119A1 (en) | Hair cosmetic | |
JPH11263721A (en) | Oil-in-water type gommage (peeling) cosmetic | |
WO2021201136A1 (en) | Oil-in-water type cosmetic emulsion preparation | |
JP5243078B2 (en) | Highly polar oil-containing oil-in-water ultrafine emulsion external preparation and method for producing the oil-in-water ultrafine emulsion external preparation | |
KR20240031068A (en) | Skin cosmetic and emulsified cosmetic | |
US20060067904A1 (en) | Cosmetic compositions containing amphiphilic silicone resin emulsifier | |
JP7348122B2 (en) | emulsified skin cosmetics | |
JP2019172625A (en) | Skin cream | |
JP7086719B2 (en) | Skin cosmetics | |
JP2007099649A (en) | Cosmetic composition | |
JP3571191B2 (en) | Water-in-oil type emulsion composition | |
WO2023047979A1 (en) | Oil-in-water emulsified cosmetic material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |